Citadel Advisors »

Sunshine Biopharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Sunshine Biopharma (SBFM) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Sunshine Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sunshine Biopharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sunshine Biopharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $116k 78k 1.49
2025-06-30 $91k 63k 1.44

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Sunshine Biopharma

Citadel Advisors
Renaissance Technologies
DRW Holdings
Two Sigma Investments
Two Sigma Securities
SBI Securities
Morgan Stanley
UBS Group
Advisor Group Holdings
National Bank Of Canada /fi/
Farther Finance Advisors
Federation des caisses Desjardins du Quebec
TD Waterhouse Canada

View all funds holding Sunshine Biopharma